GLORIA

GEOMAR Library Ocean Research Information Access

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    New York, NY :Springer,
    Keywords: Glycoconjugates. ; Electronic books.
    Type of Medium: Online Resource
    Pages: 1 online resource (590 pages)
    Edition: 1st ed.
    ISBN: 9781493911547
    Series Statement: Advances in Neurobiology Series ; v.9
    DDC: 612.8
    Language: English
    Note: Intro -- Preface -- Contents -- Contributors -- Chapter 1: Introduction to the Complexity of Cell Surface and Tissue Matrix Glycoconjugates -- 1.1 Introduction -- 1.2 Monosaccharides: Building Blocks of Glycans -- 1.3 Formation of Oligosaccharides -- 1.4 Classification of Glycans -- 1.5 Structural Features of  N -Glycans -- 1.6 Structural Features of  O -Glycans -- 1.7 Biosynthesis of  N - and  O -Glycans -- 1.8 Glycosphingolipids -- 1.9 Structural Features of the Glycan Moieties of Glycosphingolipids -- 1.10 Synthesis and Functions of the Glycan Moieties of Glycolipids -- 1.11 Glycosylphosphatidylinositol Anchors: A Special Group of Glycolipids -- 1.12 Glycosaminoglycans and Proteoglycans -- 1.13 Glycans of Cell Surface Glycoconjugates Perform a Variety of Functions -- 1.14 Summary -- References -- Chapter 2: Introduction to Cells Comprising the Nervous System -- 2.1 Introduction -- 2.2 Neurons -- 2.2.1 Dendrites -- 2.2.2 Axon -- 2.3 Glia -- 2.3.1 Astrocytes -- 2.3.2 Oligodendrocytes and Myelin -- 2.3.3 Microglia -- 2.4 Summary -- References -- Chapter 3: Synthesis, Processing, and Function of N-glycans in N-glycoproteins -- 3.1 Introduction -- 3.2 N-Glycans Are First Born on a Lipid and then Transferred "En Bloc" onto the Nascent N-Glycoprotein in the ER -- 3.3 Trimming, Reglycosylation, and Remodeling: There Are Many Ways of N-Glycoprotein Processing in the ER and Golgi -- 3.4 The Essential Toolbox of a Glycobiologist: A Brief History of the Discovery of N-Glycoprotein Biosynthesis Inhibitors and Their Impact on Our Understanding of N-Glycan Processing -- 3.5 Sweet Encounters of Proteins and Lipids: N-Glycans Affect the Subcellular Distribution and Complex Formation of Enzymes in Glycolipid Biosynthesis -- 3.6 Conclusions and Epilogue: The Tale of the Tail That Wags the Dog -- References. , Chapter 4: Synthesis of O-Linked Glycoconjugates in the Nervous System -- 4.1 Introduction -- 4.2 Biosynthesis of O-Linked Proteins -- 4.2.1 O-GalNAcylation -- 4.2.2 O - Mannosylation -- 4.2.3 O-GlcNAcylation -- 4.2.4 O-Xylosylation -- Heparan Sulfate -- Chondroitin Sulfate -- 4.2.5 O-Fucosylation -- 4.2.6 O-Glucosylation -- 4.3 Biosynthesis of O-Linked Lipids -- 4.3.1 Glucosylceramide and Glycosphingolipids -- 4.3.2 Galactosylceramide and Glycosphingolipids -- 4.3.3 Other O-Linked lipids -- Cholesterylglucoside -- Phosphatidylglucoside -- 4.4 Conclusions -- References -- Chapter 5: Chemistry and Function of Glycosaminoglycans in the Nervous System -- 5.1 Introduction -- 5.2 Glycosaminoglycan Structure and Chemistry -- 5.2.1 Chondroitin Sulfate -- Structure and Chemistry -- Synthesis and Modification of CS Chains -- CS Proteoglycans in Brain -- 5.2.2 Dermatan Sulfate -- 5.2.3 Heparin -- 5.2.4 Heparan Sulfate -- Structure and Chemistry -- Synthesis and Modification of HS Chains -- HS Proteoglycans in Brain -- 5.2.5 Keratan Sulfate -- 5.2.6 Hyaluronan -- 5.3 Function of GAGs in the Brain -- 5.3.1 GAG Interactions and Binding Partners -- 5.3.2 GAG Functions -- Neural System Development -- Brain Patterning -- Neurite Outgrowth and Migration -- Differentiation and Stem-Cell Niche -- Synaptic Plasticity -- 5.3.3 Injury Response -- 5.3.4 GAGs and Human Neural Diseases -- 5.4 Concluding Remarks -- References -- Chapter 6: Use of Glycan-Targeted Antibodies/Lectins to Study the Expression/Function of Glycosyltransferases in the Nervous System -- 6.1 Introduction -- 6.2 HNK-1 Epitope -- 6.3 O-Mannose Glycans in the Brain -- 6.4 GnT-IX Is a Brain-Specific O-Mannose Branching Enzyme -- 6.5 In Vivo Enzymatic Functions of GnT-IX and GnT-V -- 6.6 GnT-IX-Deficient Mice Show Enhanced Recovery from Demyelinating Damage -- References. , Chapter 7: From Mass Spectrometry-Based Glycosylation Analysis to Glycomics and Glycoproteomics -- 7.1 Overview and Scope -- 7.2 Mass Spectrometry for Glycosylation Analysis -- 7.2.1 A Primer for MALDI-MS and LC-ESI-MS -- 7.2.2 LC Separation -- 7.2.3 Chemical Derivatization -- 7.2.4 MS/MS Sequencing -- 7.2.5 Summary and Perspectives -- 7.3 Increasing the Breadth and Depth of MS-Based Glycomic Coverage -- 7.3.1 Addressing Poly- N -acetyllactosaminoglycans -- 7.3.2 Addressing Terminal Disialyl Motif and Polysialylation -- 7.3.3 Addressing Sulfoglycomics -- 7.3.4 Summary and Perspectives -- 7.4 From Glycomics to Glycobiology-Driven Glycoproteomics -- 7.4.1 Raison d'etre and the Inadequacy of Only Defining Site Occupancy -- 7.4.2 MS/MS Sequencing and Identification of Glycopeptides -- 7.5 Closing and Future Prospects -- References -- Chapter 8: Structural Analysis of Oligosaccharides and Glycoconjugates Using NMR -- 8.1 Introduction -- 8.2 Basic NMR Phenomena -- 8.3 Chemical Shifts as Structural Probes -- 8.4 Through "BOND" and Through "SPACE" Interactions -- 8.5 Relaxation and Molecular Motion -- 8.6 Paramagnetic Effects as Sources of Long-Distance Information -- 8.7 Chemical Exchange: Dynamic Aspects in NMR -- 8.8 NMR Tools for Intermolecular Interaction Analysis -- 8.8.1 Oligosaccharide-Protein Interactions -- 8.8.2 Protein Binding to Glycolipid Clusters -- 8.9 Liaisons Between NMR and Computation -- References -- Chapter 9: Glycolipid and Glycoprotein Expression During Neural Development -- 9.1 Introduction -- 9.2 Glycobiology During Early Embryogenesis -- 9.3 Neural Tube Formation -- 9.4 Neuroepithelial Cells and Radial Glial Cells -- 9.4.1 Neural Stem Cells in Development -- Notch -- 9.4.2 Neuroepithelial Cells, Radial Glial Cells, and Intermediate Progenitor Cells -- NECs -- RGCs -- IPCs -- SSEA-1 -- Prominin-1 -- Gangliosides. , Heparin Sulfate Proteoglycans and Chondroitin Sulfate Proteoglycans -- 9.5 Neurogenesis -- 9.5.1 Polysialic Acid-Neural Cell Adhesion Molecule -- 9.5.2 9-O-Acetyl GD3 -- 9.5.3 Gangliosides -- 9.6 Gliogenesis -- 9.6.1 Oligodendrogenesis -- A2B5 -- NG2 -- O4 and O1 -- 9.6.2 Astrogliogenesis -- gp130 -- PtdGlc -- Gangliosides -- 9.7 Adult NSCs and Niche -- 9.7.1 SVZ -- 9.7.2 SGZ -- 9.7.3 Glycoconjugates in Adult NSCs -- 9.7.4 Lectins -- 9.8 Neural Crest Cells -- 9.8.1 HNK-1 -- 9.8.2 PSA-NCAM -- 9.8.3 Other Glycoconjugates -- 9.9 Future Studies -- References -- Chapter 10: Gangliosides and Cell Surface Ganglioside Glycohydrolases in the Nervous System -- 10.1 Gangliosides -- 10.2 Gangliosides and Membrane Organization -- 10.3 Metabolic Pathways of Gangliosides -- 10.4 Plasma Membrane-Associated Enzymes and Ganglioside Pattern -- 10.5 Plasma Membrane Glycosphingolipid Hydrolases in the Nervous System -- 10.5.1 Sialidase Neu3 -- 10.5.2 β-Glucocerebrosidases -- 10.5.3 β-Galactosidases -- 10.5.4 β-Hexosaminidases -- 10.6 Conclusions -- References -- Chapter 11: Role of Myelin-Associated Glycoprotein (Siglec-4a) in the Nervous System -- 11.1 Introduction -- 11.2 MAG Structure and Expression -- 11.3 Role of MAG in Axon-Myelin Interaction/Stability -- 11.4 MAG as an Inhibitor of Axon Regeneration -- 11.5 Nurturing/Protective Properties of MAG on Neurons -- 11.6 MAG as a Functional Receptor in Oligodendrocytes -- 11.7 Future Perspectives -- References -- Chapter 12: Role of Galactosylceramide and Sulfatide in Oligodendrocytes and CNS Myelin: Formation of a Glycosynapse -- 12.1 Requirement for Myelin Glycosphingolipids for Maintenance of the Myelin Sheath -- 12.2 Functions of Myelin Glycosphingolipids -- 12.3 Involvement of OLG/Myelin GSLS in Signaling -- 12.4 Natural Ligands That Interact with GalC and SGC and Transmit Signals Across Apposed Membranes. , 12.5 Binding and Effect of Multivalent Glyco-nanoparticles on OLGS -- 12.6 Receptors in OLGS Which Interact with Multivalent Gal/SGal by Trans Interactions -- 12.7 GalC/SGC Signaling Releases Cytoskeletal Restriction of Membrane Domains -- 12.8 Role of MBP in Transmission of GalC/SGC-Mediated Signal -- 12.9 Role of Glycosynapses in OLGS or Myelin -- 12.10 Treatment of Demyelinating Disease by Stimulation of OLGS by GSL Cross-Linking -- References -- Chapter 13: Glycosignaling: A General Review -- 13.1 Introduction: Definition of "Glycosignaling" -- 13.2 Isolation of Glycosignaling Complexes from Brain -- 13.3 Glycosignaling, Biosynthesis, and Brain Development -- 13.4 The Glycocalyx as a Barrier to Glycosignaling -- 13.5 Glycosignaling Heterogeneity in Specific Brain Regions -- 13.6 Evidence That Fatty Acids and Sphingosine Base Heterogeneity Can Affect Glycosignaling: Toxins -- 13.7 Glycosignaling, Rho-GTPase, and Axonal Growth -- 13.8 Glycosignaling and Protein Phosphorylation -- 13.9 Lysosomal Storage Modifies Glycosignaling -- 13.10 Future Directions for Glycosignaling in the Brain -- References -- Chapter 14: Glycosphingolipids in the Regulation of the Nervous System -- 14.1 Introduction -- 14.2 Glycosphingolipids in Cultured Cells -- 14.2.1 Gangliosides Modulate Signals Transduced by Neurotrophic Factors/Receptors -- 14.2.2 Essential Roles of GSLs for Development of Multicellular Organisms -- 14.3 Impact of KO of Glycosyltransferase Genes Located at Stem Steps of GSL Synthesis -- 14.3.1 KO of ST3GAL5 (GM3 Synthase) in Mice -- 14.3.2 KO of UGT8 (GalCer Synthase) and GAL3ST1 (Sulfatide Synthase) in Mice -- 14.3.3 LacCer Synthase KO Mice -- 14.4 Compensation for Lost Functions by Remaining GSLS -- 14.5 Double KO Exhibited More Severe Phenotypes -- 14.6 Response to Neurodegeneration by Modification of Gene Expression in the DKO mice. , 14.7 Mechanisms by Which Gangliosides May Maintain the Integrity of the CNS.
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    Cham :Springer International Publishing AG,
    Keywords: Glycoconjugates. ; Electronic books.
    Type of Medium: Online Resource
    Pages: 1 online resource (506 pages)
    Edition: 2nd ed.
    ISBN: 9783031123900
    Series Statement: Advances in Neurobiology Series ; v.29
    DDC: 612.8
    Language: English
    Note: Intro -- Preface -- Postscript: In Memoriam -- Contents -- Chapter 1: Introduction to the Complexity of Cell Surface and Tissue Matrix Glycoconjugates -- 1 Introduction -- 2 Monosaccharides: Building Blocks of Glycans -- 3 Formation of Oligosaccharides -- 4 Classification of Glycans -- 5 Structural Features of N-Glycans -- 6 Structural Features of O-Glycans -- 7 Biosynthesis of N- and O-Glycans -- 8 Glycosphingolipids -- 9 Structural Features of the Glycan Moieties of Glycosphingolipids -- 10 Synthesis and Functions of the Glycan Moieties of Glycolipids -- 11 Glycosylphosphatidylinositol Anchors: A Special Group of Glycolipids -- 12 Glycosaminoglycans and Proteoglycans -- 13 Glycan-Protein Interactions -- 14 Glycans of Cell Surface Glycoconjugates Perform a Variety of Functions -- 15 Summary -- References -- Chapter 2: Cells of the Central Nervous System: An Overview of Their Structure and Function -- 1 Introduction -- 2 Neurons -- 2.1 Neuronal Cell Body -- 2.2 Cytoskeleton -- 2.3 Dendrites -- 2.4 Axon -- 2.5 Synapse -- 3 Supporting Cells -- 3.1 Astrocytes -- 3.2 Oligodendrocytes -- 3.3 Microglia -- 3.4 NG2 Cells (Polydendrocytes) -- 3.5 Ependymal Cells -- 4 Extracellular Matrix -- 5 Concluding Remarks -- References -- Chapter 3: Synthesis, Processing, and Function of N-Glycans in N-Glycoproteins -- 1 Introduction -- 2 N-glycans Are First Born on a Lipid and Then Transferred "En Bloc" onto the Nascent N-glycoprotein in the ER -- 3 Trimming, Reglycosylation, and Remodeling: There Are Many Ways of N-glycoprotein Processing in the ER and Golgi -- 4 The Essential Toolbox of a Glycobiologist: A Brief History of the Discovery of N-glycoprotein Biosynthesis Inhibitors and Their Impact on Our Understanding of N-glycan Processing. , 5 Sweetening the Bond or Sugar-Coating Bad News: Recent Advances in the Role of N-glycans for Virus Infections and Immune Responses -- 6 Sweet Encounters of Glycoproteins and Glycolipids: N-glycans Affect the Subcellular Distribution and Complex Formation of Enzymes in Glycolipid Biosynthesis -- 7 Conclusions and Epilogue: The Tale of the Tail That Wags the Dog -- References -- Chapter 4: Synthesis of O-Linked Glycoconjugates in the Nervous System -- 1 Introduction -- 2 Biosynthesis of O-Linked Proteins -- 2.1 O-GalNAcylation -- 2.2 O-Mannosylation -- 2.3 O-GlcNAcylation -- 2.4 O-Xylosylation -- 2.5 O-Fucosylation -- 2.6 O-Glucosylation -- 3 Biosynthesis of O-Linked Lipids -- 3.1 Glucosylceramide and Glycosphingolipids -- 3.2 Galactosylceramide and Glycosphingolipids -- 3.3 GlcCer and GM3 Synthase Deficiency in Human and Mouse -- 3.4 Other O-Linked Lipids - New Glucose-Related Lipids -- 4 Conclusions -- References -- Chapter 5: Chemistry and Function of Glycosaminoglycans in the Nervous System -- 1 Introduction -- 2 Glycosaminoglycan Structure and Chemistry -- 2.1 Chondroitin Sulfate (CS) -- 2.1.1 Structure and Chemistry -- 2.1.2 Synthesis and Modification of CS Chains -- 2.1.3 CS Proteoglycans (CSPGs) in Brain -- 2.2 Dermatan Sulfate (DS) -- 2.3 Heparin -- 2.4 Heparan Sulfate (HS) -- 2.4.1 Structure and Chemistry -- 2.4.2 Synthesis and Modification of HS Chains -- 2.4.3 Heparan Sulfate Proteoglycans (HSPGs) in Brain -- 2.5 Keratan Sulfate (KS) -- 2.6 Hyaluronan (HA) -- 3 Function of GAGs in the Brain -- 3.1 GAG Interactions and Binding Partners -- 3.2 GAG Functions During Brain Development -- 3.2.1 Neural System Development and Lineage Specification -- 3.2.2 Brain Patterning -- 3.2.3 Neurite Outgrowth, Axonal Pathfinding and Migration -- 3.2.4 Differentiation and Stem-Cell Niche -- 3.2.5 Synaptic Plasticity. , 3.3 GAG Function in CNS-Associated Disorders and Injury -- 3.3.1 Injury Response -- 3.3.2 Neurological Disorders -- 3.3.3 Inflammation -- 3.3.4 Tumorigenesis -- 4 Concluding Remarks -- References -- Chapter 6: Structural Analysis of Oligosaccharides and Glycoconjugates Using NMR -- 1 Introduction -- 2 Basic NMR Phenomena -- 3 Chemical Shifts as Structural Probes -- 4 Through "BOND" and Through "SPACE" Interactions -- 5 Relaxation and Molecular Motion -- 6 Paramagnetic Effects as Sources of Long-Distance Information -- 7 Chemical Exchange: Dynamic Aspects in NMR -- 8 NMR Tools for Intermolecular Interaction Analysis -- 8.1 Oligosaccharide-Protein Interactions -- 8.2 Protein Binding to Glycolipid Clusters -- 9 Liaisons Between NMR and Computation -- References -- Chapter 7: Glycans and Carbohydrate-Binding/Transforming Proteins in Axon Physiology -- 1 Introduction -- 2 Axon Determination/Early Neuronal Differentiation -- 3 Axon Guidance -- 3.1 Axon Guidance by Glycosylated Cell Adhesion Molecules (CAMs) -- 3.2 Glycosaminoglycans in Axon Guidance -- 3.3 Galectins and Their Interactions with Guidance Cues in the Adult Olfactory System -- 4 Axon/Glia Interactions -- 5 Nerve Impulse Generation/Transmission -- 5.1 Voltage-Gated Ion Channels -- 5.2 Voltage-Gated Sodium Channels -- 5.3 Voltage-Gated Potassium Channels -- 5.4 Voltage-Gated Calcium Channels -- 5.5 O-Linked β-N-Acetylglucosaminylation of AIS Proteins -- 6 Axon Regeneration -- 7 New Perspective in CNS Regulation Through Glycan-Lectin Interactions in the Microbiota-Gut-Brain Axis -- References -- Chapter 8: Neurological Consequences of Congenital Disorders of Glycosylation -- 1 Introduction -- 2 Classification -- 2.1 N-Linked Glycosylation Defects -- 2.2 O-Linked Glycosylation Defects -- 2.3 Disorders of Glycosylphosphatidylinositol (GPI) Anchor Biosynthesis. , 2.4 Disorders of Glycosphingolipid (GSL) Glycosylation -- 2.5 Disorders of Multiple Glycosylation Pathways -- 2.6 Recently Described CDG with Neurological Presentation -- 3 Markers/Biochemical Abnormalities -- 4 Congenital Brain Abnormalities -- 5 Epilepsy -- 6 Developmental Delay/Intellectual Disability -- 7 Ataxia -- 8 Neuromuscular Presentation -- 9 Spasticity -- 10 Autistic Features -- 11 Extrapyramidal Manifestation -- 12 Treatment Options -- 13 Conclusions and New Perspectives -- References -- Chapter 9: Brain O-GlcNAcylation: From Molecular Mechanisms to Clinical Phenotype -- 1 Introduction -- 2 O-GlcNAc Is a Ubiquitous Monosaccharide That Cycles Onto and Off Serine and Threonine -- 2.1 O-GlcNAc Is Not Elongated to Yield Complex Oligosaccharides -- 2.2 O-GlcNAc Is Mostly Expressed on the Inside of Cells in Multicellular Organisms -- 2.3 O-GlcNAc Can Be Dynamically Attached and Removed -- 3 O-GlcNAc Is Added to Proteins by OGT and Removed by OGA -- 3.1 Only Two Enzymes Regulate the Cycling of O-GlcNAc -- 3.2 O-GlcNAc Transferase -- a Highly Conserved Glycosyltransferase Present in the Nucleus & -- Cytosol -- 3.3 O-GlcNAcase -- a Cytosolic O-β-GlcNAc Hydrolase with Neutral pH Optima -- 4 O-GlcNAc Is Highly Expressed in the Nervous System -- 4.1 O-GlcNAc Is Found Throughout the Brain -- 4.2 Thousands of Neuronal Proteins Are Modified by O-GlcNAc -- 4.3 O-GlcNAc Regulates Diverse Cellular Processes -- 5 O-GlcNAc Is Essential for Brain Function -- 5.1 Early and Late Brain Development Depends Upon O-GlcNAc Cycling -- 5.2 O-GlcNAc Underlies Learning and Memory -- 5.3 Impaired O-GlcNAc Cycling Contributes to Neurodegenerative Disease -- 5.4 O-GlcNAc Mediates Central Control of Metabolism -- 6 Summary and Outlook -- References -- Chapter 10: Ganglioside Microdomains on Cellular and Intracellular Membranes Regulate Neuronal Cell Fate Determination. , 1 Introduction -- 2 Ganglioside Multifunction in Cell Membranes and Intracellular Organelles -- 3 Ganglioside microdomains for Neuronal Cell Fate Determination -- 4 GD3-EGFR -- 5 GD3 Regulates Mitochondrial Dynamics by Interacting with Drp1 -- 6 GD3 Amplifies SOX2 Expression and GM1 Promotes DCX Expression -- 7 GM1 Binds to Neuronal Gene Promoter Regions -- 8 Nuclear GM1 Promotes Neuronal Gene Expression -- 9 Other Gangliosides for NSC Specification -- 10 Future Studies -- References -- Chapter 11: Gangliosides and Cell Surface Ganglioside Metabolic Enzymes in the Nervous System -- 1 Gangliosides -- 1.1 Ceramide: The Lipid Portion of Gangliosides -- 1.2 The Oligosaccharide Portion of Gangliosides -- 2 Gangliosides and Membrane Organization -- 3 Metabolic Pathways of Gangliosides -- 4 Plasma Membrane-Associated Enzymes and Ganglioside Pattern -- 5 Sialidases, Sialyltransferases and Plasma Membrane Sialidase Neu3 -- 6 β-Hexosaminidase and N-Acetylgalactosaminyltransferase -- 7 β-Glucocerebrosidase -- 8 β-Galactosidase -- 9 Membrane Dynamics: A Non-canonical Pathway Involved in the Establishment of the GSL Profile at the Plasma Membrane -- 10 Conclusions -- References -- Chapter 12: Neuronal Ganglioside and Glycosphingolipid (GSL) Metabolism and Disease -- 1 Historical Aspects of Structure, Location and Function of GSLs -- 2 Significance and Function of Neuronal GGs -- 3 Intracellular Pathways of GG and GSL Metabolism -- 4 Emerging Concepts of GSL & -- GG Metabolism at Organellar Membranes -- 5 Emerging Topology of Glycolipid Biosynthesis -- 6 Generation of Cell-Type-Specific Ganglioside Patterns -- 7 Enzyme Catalysis at Membrane Surfaces -- 8 GSL Biosynthesis and Salvage Pathways -- 8.1 Ceramide Synthesis -- 8.2 Ganglioside Synthesis and Function -- 9 Inherited Errors of GG Biosynthesis -- 10 Remodeling and Recycling of Cell Surface Gangliosides. , 11 Concepts of the Constitutive Degradation of Gangliosides and Glycosphingolipids at ILVs.
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    Cham : Springer International Publishing | Cham : Imprint: Springer
    Keywords: Neurosciences. ; Zoology. ; Neurochemistry.
    Description / Table of Contents: 1. Introduction to the complexity of cell surface and tissue matrix glycoconjugates. -- 2. Introduction to cells comprising the nervous system. -- 3. Synthesis -- processing -- and function of N-glycans in N-glycoproteins. -- 4. Synthesis of O-linked glycoconjugates in the nervous system. -- 5. Chemistry and function of glycosaminoglycans in the nervous system. -- 6. Use of glycan-targeted antibodies/lectins to study the expression/function of glycosyltransferases in the nervous system. -- 7. Capillary electrophoresis and mass spectrometry-based glycosylation analysis in glycomics and glycoproteomics. -- 8. Structural analysis of oligosaccharides and glycoconjugates using NMR. -- 9. Glycolipid and glycoprotein expression during neural development. -- 10. Gangliosides and cell surface ganglioside glycohydrolases in the nervous system (request them to include gal-cer and sulfatide). -- 11. Role of myelin-associated glycoproteins in the peripheral nervous system. -- 12. Glycosignaling: a general review. -- 13. Glycosphingolipids in the regulation of the nervous system. -- 14. O-GlcNAcylation of neuronal proteins: Roles in neuronal functions and in neurodegeneration. -- 15. Glycoconjugates in nuclear membranes. -- 16. N-glycosylation in regulation of the nervous system. -- 17. Role of carbohydrates in the interaction of pathogens with neural cells. -- 18. Glycoconjugate changes in aging and age-related diseases. -- 19. Gangliosides and glycolipids in neurodegenerative disorders. -- 20. Inborn errors of glycosphingolipid catabolism and potential treatment. -- 21. Neurological aspects of human glycosylation disorders. -- 22. Glycoconjugates and neural tumors. -- 23. Galectins and neuroinflammation . -- 24. Glycoconjugates and neuroimmunological diseases. -- 25. Targeting nanoparticle drug carriers to the brain. -- 26. Use of quantum dots to treat inherited lysosomal storage diseases. -- 27. MALDI-FTICR MS imaging of nervous system glycoconjugates.
    Type of Medium: Online Resource
    Pages: 1 Online-Ressource(XII, 501 p. 96 illus., 73 illus. in color.)
    Edition: 2nd ed. 2023.
    ISBN: 9783031123900
    Series Statement: Advances in Neurobiology 29
    Language: English
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    ISSN: 1471-4159
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Notes: Abstract: The glycosphingolipid (GSL) composition of cells changes dramatically during cellular differentiation. Nerve growth factor (NGF) or forskolin (FRK) are known to induce cellular differentiation including process formation in PC12 pheochromocytoma cells. In this respect, we present the NGF/FRK-dependent regulation of glycosyltransferase activities and the corresponding GSL expression in PC12D cells. After treatment of PC12D cells with NGF or FRK, the cell processes, including varicoses and growth cones, became strongly immunoreactive with an antibody against a unique globo-series neutral GSL, Galα1-3Galα1-4Galβ1-4Glcβ1-1′Cer (GalGb3), and the activity of GalGb3-synthase increased significantly. Other glycosyltransferase activities, including GM1 containing blood group B determinant (BGM1)-, GM3-, GD1a-, and GM2-synthases, also increased significantly upon NGF treatment, but the immunoreactivity against BGM1 did not show any appreciable change. For the parent PC12 cells, NGF/FRK treatment significantly increased the percentage of anti-GalGb3 positive cells and induced some immunoreactive cell processes. Because the parent PC12 cells do not express appreciable amounts of GalGb3, and because PC12D cells are considered to be more differentiated than the parent PC12 cells, the expression of GalGb3 and the increase of GalGb3-synthase activity may be closely related to the cellular differentiation process in this cell line.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    Electronic Resource
    Electronic Resource
    Oxford, UK : Blackwell Science Ltd
    Journal of neurochemistry 64 (1995), S. 0 
    ISSN: 1471-4159
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Notes: Abstract: The composition of tissue gangliosides is thought to result mainly from the active regulation and selective expression of specific enzymes responsible for their metabolism. In the last few years, we have purified several rat brain sialyltransferases to homogeneity; the availability of these highly purified enzymes enabled us to investigate their regulation and expression at the molecular level. Thus, we studied the regulation of sialyltransferase activities, in particular, CMP-NeuAc:GM1 and CMP-NeuAc:LacCer sialyltransferases by a phosphorylation/dephosphorylation mechanism. Protein kinase C was added to a standard enzyme assay mixture containing [γ-32P]ATP, and the activity of the enzyme was measured after various incubation times. We found that treatment of several sialyltransferases by protein kinase C decreased their activities in a time-dependent manner. Analyses of 32P-labeled amino acids revealed that the major phosphorylation site of CMP-NeuAc:GM1 α2→3 sialyltransferase (ST-IV) was serine and that for CMP-NeuAc:LacCer α2→3 sialyltransferase (ST-I) was primarily threonine. Partial recovery of the enzyme activity could be achieved by treatment of the phosphorylated sialyltransferases with rat brain protein phosphatase. We conclude that the activities of sialyltransferases can be modulated by protein kinase C and protein phosphatase and this may represent a potential regulatory mechanism for ganglioside biosynthesis.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    ISSN: 1471-4159
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Notes: Abstract: Several gangliosides of human nervous tissues have been reported to be potential target antigens in autoimmune neuropathies. To explain the diversity of clinical symptoms in patients with antiganglioside antibodies, we have searched for ganglioside antigens that are specific to individual nervous tissues such as motoneurons, peripheral motor nerves, and sensory nerves. Although the major ganglioside compositions were not different among human peripheral motor and sensory nerves, fucosyl-GM1 was found to be expressed in sensory nervous tissue but not in spinal cord, motor nerve, and sympathetic ganglia. Sera from several patients with sensory nerve involvement also reacted with fucosyl-GM1 as well as GM1. Thus, fucosyl-GM1 may be a responsible target antigen for developing sensory symptoms in some patients with autoimmune neuropathies.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    Electronic Resource
    Electronic Resource
    Oxford, UK : Blackwell Publishing Ltd
    Journal of neurochemistry 57 (1991), S. 0 
    ISSN: 1471-4159
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Notes: : Oligodendroglial nuclei isolated from rat brains at different stages of myelinogenesis (10,18, and 30 days of age) were incubated with (γ-32P]ATP and extracted with 0.75 Mperchloric acid to yield a fraction of nonacidic chromatin proteins. The protein extracts were then analyzed by poly-acrylamide gel electrophoresis. The phosphorylation pattern of these proteins was found to be different for different age groups. In 10-day-old rat Oligodendrocytes the most extensive phosphorylation occurred in low molecular mass species (〈30 kDa), in contrast to fractions obtained from 18-and 30-day-old rat Oligodendrocytes which showed a significantly higher labeling of the proteins with molecular masses 〉30 kDa. The phosphorylation of the latter species was greatly stimulated by the presence of cyclic AMP in the incubation media. The results suggest that the phosphorylation of specific nuclear proteins, which may play a regulatory role at different stages of oligodendroglial maturation and myelinogenesis, may be at least partially modulated by intracellular cyclic AMP.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    Electronic Resource
    Electronic Resource
    Oxford, UK : Blackwell Publishing Ltd
    Journal of neurochemistry 55 (1990), S. 0 
    ISSN: 1471-4159
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Notes: In patients with neuropathy associated with para-proteinemia, there are monoclonal immunoglobulin M antibodies reacting with myelin-associated glycoprotein and sulfated glucuronyl glycolipids. There are indications that the monoclonal antibodies may be responsible for these neuropathies. However, the mechanism by which the antibodies gain access to the nervous tissue, which is separated by the blood-brain barrier or blood-nerve barrier, is still unknown. In this study, we examined the presence of the sulfated glucuronyl glycolipid antigens on brain endothelial cells. Micro-vessels were isolated from adult Lewis rat brain cortex. Sulfated glucuronyl paragloboside (SGPG) was detected in the acidic lipid fraction by a TLC immunostaining method. Immunofluorescence studies showed positive staining on the surface of microvessels. In addition, SGPG could be detected in the cultured endothelial cells of human umbilical vein. These findings suggest that the endothelial cells contain an-tigenic sites for interaction with the autoantibodies. This type of interaction may result in damages to the endothelial cell function and may be responsible for changes in the blood-brain barrier permeability and the ensuing penetration of large molecules, such as immunoglobulins, into the endo-neurial space.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    ISSN: 1471-4159
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Notes: Abstract: Peripheral nerve glycolipids, with which anti-myelin-associated glycoprotein (MAG) antibodies from patients with demyelinating neuropathy and plasma cell dyscrasia cross-react, proved to be novel glycosphingolipids containing a sulfated glucuronyl residue. Consequently, there has been much interest in the immunological role that these sulfated glucuronyl-glycosphingolipids (SGGLs) may play in the pathogenesis of this disorder. For the determination of the distribution of these glycolipids in various nervous tissues and, thereby, the elucidation of their pathoge-nicity, a quantitative immunostaining-TLC method for their detection has been devised. Using this method, we demonstrated that these glycolipids were distributed in greatly different amounts in the peripheral nerves from human, bovine, chicken, rat, and rabbit. Subcellular localization studies of bovine peripheral nerve also demonstrated that they were enriched in the axolemma-enriched fraction and present in glial-related membranes in lower concentrations. In addition, these glycolipids were present in bovine dura mater and transformed rat Schwann cells. These biochemical results suggest that not only myelin but also axons could be involved as targets of the anti-MAG antibody in macroglobulinemia neuropathy, and it may also be necessary to examine anti-SGGL activity in patients with axonal neuropathy associated with plasma cell dyscrasia.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    ISSN: 1471-4159
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Notes: Abstract: To characterize the sialyltransferase-IV activity in brain tissues, the activities of GM1b-, GD1a-, GT1b-, and GQ1c-synthases in adult cichlid fish and rat brains were examined using GA1, GM1, GD1b, or a cod brain ganglioside mixture as the substrate. The GD1a-synthase activity in the total membrane fraction from cichlid fish brain required divalent cations such as Mg2+ or Mn2+ and Triton CF-54 for its full activity. The Vmax value was 1,340 pmol/mg of protein/h at an optimal pH of 6.5, whereas the apparent Km values for CMP-sialic acid and GM1 were 172 and 78 µM, respectively. Cichlid fish and rat brains also contained GM1b-, GT1b-, and GQ1c-synthase activities. The ratio of GM1b-, GD1a-, and GT1b-synthase activities in fish brain was 1.00:0.89:1.13, respectively, and in rat brain 1.00:0.60:0.63. Incubation of fish brain membranes with a cod brain ganglioside mixture, which contains GT1c, and [3H]CMP-sialic acid produced radiolabeled GQ1c. It is interesting that the adult rat brain also contains an appreciable level of GQ1c-synthase activity despite its very low concentrations of c-series gangliosides. The GD1a- or GQ1c-synthase activity in fish and rat brain was inhibited specifically by coincubation with the glycolipids that serve as the substrates for other sialyltransferase-IV reactions. Thus, the GD1a-synthase activity was inhibited by GA1 and GD1b, but not by LacCer, GM3, or GD3. In a similar manner, the synthesis of GQ1c was suppressed by GA1, GM1, and GD1b, but not by LacCer, GM3, or GD3. The GD1a-synthase activity directed toward endogenous GM1 was inhibited by GA1 or GT1b, whereas the endogenous GT1b-synthase activity was suppressed by GA1 or GM1. GA1, GM1, and GD1b did not affect the endogenous GM3- and GD3-synthase activities. These results clearly demonstrate that sialyltransferase-IV in brain tissues catalyzes the reaction for GQ1c synthesis in the c-pathway as well as the corresponding steps in the asialo-, a-, and b-pathway in ganglioside biosynthesis.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...